Premium
Nov 12, 2026
•
3 min read
Organigram CEO James Yamanaka says in an exclusive interview that Aurora’s European medical business will drive growth, even as Curaleaf argues the C$7.80 deal is a bad one for Organigram shareholders.
DEA turns away medical businesses in six states
Nov 11, 2026
4 min read
Texas legislators file reform bills
2 min read
The state’s new rules expand medical access, cut security costs and loosen restrictions for cannabis retailers.
Nov 10, 2026
Ryan Dominguez returns after Question 8’s defeat in Massachusetts
Nov 9, 2026
Counting down to Cultivated in Las Vegas
Who's moving up? Who's moving on? Who is hiring?
Nov 6, 2026
$OGI CEO joins Cultivated Live at 10 am Eastern
Nov 5, 2026
GTI won’t bifurcate
Nov 4, 2026
Cannabis and the midterms
Nov 3, 2026
Exclusive: October's New York Brand Power Rankings
Nov 2, 2026
Hemp beverage fire sales
Oct 30, 2026
With a Nov. 12 deadline approaching, THC beverage makers are slashing prices, halting investments and rethinking their businesses.
Could Wisconsin be the next cannabis market?
Oct 29, 2026
Cannabis execs donate to both parties
Oct 28, 2026
Missouri Retail Price Index for October 2026
Oct 27, 2026
Alcohol distributors defend hemp drinks
